Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...